Fatigue as the main presenting symptom of chronic inflammatory demyelinating polyradiculoneuropathy: a study of 11 cases

被引:32
作者
Boukhris, S
Magy, L
Gallouedec, G
Khalil, M
Couratier, P
Gil, J
Vallat, JM
机构
[1] Hop Univ Dupuytren, Serv Neurol, Dept Neurol, F-87042 Limoges, France
[2] Dupuytren Univ Hosp, UF Rech Clin & Biostat, F-87042 Limoges, France
关键词
CIDP; fatigue; nerve biopsy; nerve conduction study; polyneuropathy;
D O I
10.1111/j.1085-9489.2005.10311.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Fatigue has been shown to be more frequent than previously thought in immune-mediated polyneuropathies. However, fatigue has not been reported as the main cause of referral in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients. Between January 2001 and December 2003, we investigated 11 patients referred for fatigue, for which we established a final diagnosis of CIDP. All patients had at least two clinical examinations including assessment of the fatigue severity scale (FSS) and one electrophysiological and laboratory work up. Additionally, 10 of the 11 patients had a nerve biopsy. There were 11 male patients. Mean age at onset was 53 11 years. Main cause of referral was fatigue in all patients. Additional symptoms included cramps (one case), distal paresthesias (six cases), limb pain (seven cases) and vasomotor disturbances (one case). Cerebrospinal fluid (CSF) analysis displayed a moderate increase in protein content in four patients. Electrophysiological analysis showed abnormalities in all patients. Among 11 patients, one fulfilled the American Academy of Neurology electrodiagnostic criteria for CIDP and three fulfilled the inflammatory neuropathy cause and treatment group or the Nicolas et al. criteria. In the eight remaining patients, a nerve biopsy confirmed the diagnosis of CIDP. Ten patients were treated, among which seven showed a significant improvement based on the FSS scale. This study shows that fatigue is a possible cause of referral for patients with CIDP and, like previous reports, emphasizes the lack of sensitivity of widely accepted electrophysiological criteria of CIDP. Long-term follow up of these patients is warranted to determine the prognosis of these minimal forms of CIDP and establish the best therapeutic strategy in such cases.
引用
收藏
页码:329 / 337
页数:9
相关论文
共 36 条
[11]  
DYCK PJ, 1975, MAYO CLIN PROC, V50, P621
[12]   Cytokine mRNA expression in patients with multiple sclerosis and fatigue [J].
Flachenecker, P ;
Bihler, I ;
Weber, F ;
Gottschalk, M ;
Toyka, KV ;
Rieckmann, P .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (02) :165-169
[13]   Chronic inflammatory demyelinating polyneuropathy: Clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy [J].
Gorson, KC ;
Allam, G ;
Ropper, AH .
NEUROLOGY, 1997, 48 (02) :321-328
[14]   INFLUENCE OF TEMPERATURE-CHANGES ON MULTIPLE-SCLEROSIS - CRITICAL-REVIEW OF MECHANISMS AND RESEARCH POTENTIAL [J].
GUTHRIE, TC ;
NELSON, DA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 (01) :1-8
[15]   Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy [J].
Hughes, R ;
Bensa, S ;
Willison, H ;
Van den Bergh, P ;
Comi, G ;
Illa, I ;
Nobile-Orazio, E ;
van Doorn, P ;
Dalakas, M ;
Bojar, M ;
Swan, A .
ANNALS OF NEUROLOGY, 2001, 50 (02) :195-201
[16]   THE FATIGUE SEVERITY SCALE - APPLICATION TO PATIENTS WITH MULTIPLE-SCLEROSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
KRUPP, LB ;
LAROCCA, NG ;
MUIRNASH, J ;
STEINBERG, AD .
ARCHIVES OF NEUROLOGY, 1989, 46 (10) :1121-1123
[17]   Fatigue in multiple sclerosis - Definition, pathophysiology and treatment [J].
Krupp, LB .
CNS DRUGS, 2003, 17 (04) :225-234
[18]   Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England [J].
Lunn, MPT ;
Manji, H ;
Choudhary, PP ;
Hughes, RAC ;
Thomas, PK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (05) :677-680
[19]   Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy [J].
Magda, P ;
Latov, N ;
Brannagan, TH ;
Weimer, LH ;
Chin, RL ;
Sander, HW .
ARCHIVES OF NEUROLOGY, 2003, 60 (12) :1755-1759
[20]  
McLeod JG, 1999, ANN NEUROL, V46, P910, DOI 10.1002/1531-8249(199912)46:6<910::AID-ANA14>3.3.CO